Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023418 (
leukemia
)
93,477
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Axotrophin (axot) is a newly characterised stem cell gene and mice that lack
axotrophin
are viable and fertile, but show premature neural degeneration and defective development of the corpus callosum. By comparing axot+/+, axot+/- and axot-/- littermates, we now show that
axotrophin
is also involved in immune regulation. Both T cell proliferation and T cell-derived
leukaemia
inhibitory factor (LIF) were suppressed by
axotrophin
in a gene-dose-dependent manner. Moreover, a role for
axotrophin
in the feedback regulation of LIF is implicated. This is the first evidence that fate determination mediated by LIF maybe qualified by
axotrophin
.
...
PMID:Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune tolerance. 1567 Aug 16
Immune self-tolerance is controlled by a subset of T lymphocytes that are regulatory (Treg) and epigenetically programmed to suppress auto-reactive immune effector cells in vivo. By extrapolation, donor-specific transplantation tolerance might be controlled by donor-specific Treg that have acquired the appropriate epigenetic program for tolerance. Although such tolerance has yet to be achieved in man, proof of concept comes from mouse models where regulatory transplantation tolerance can be induced within the complex micro-environment of the spleen or draining lymph node. By studying whole spleen cell populations in a murine model of transplantation tolerance we have incorporated a complexity of environmental factors when looking for specific features that characterize tolerance versus aggression. This approach has revealed unexpected patterns of gene activity in tolerance and most notably that a novel stem cell gene,
axotrophin
, regulates T lymphocyte responsiveness both in terms of proliferation and in release of
leukaemia
inhibitory factor (LIF). Since LIF is a regulator of stem cells in addition to being a key neuropoietic cytokine, these preliminary results linking both
axotrophin
and LIF to transplantation tolerance lead us to propose that regulatory pathways encoded during the epigenetic development of Treg cells are related to pathways that regulate fate determination of stem cells.
...
PMID:Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance. 1614 33
In an ex vivo mouse model, regulatory transplantation tolerance is not only linked to Foxp3, but also to release of
leukaemia
inhibitory factor (LIF) and to expression of
axotrophin
(also known as MARCH-7), a putative ubiquitin E3 ligase associated with feedback control of T cell activation and of T cell-derived LIF. Given this coordinate correlation with tolerance, we now ask if Foxp3 expression is influenced by LIF or by
axotrophin
. In spleen cells from allo-rejected mice we found that exogenous LIF reduced interferon gamma release in response to donor antigen by 50%, but LIF had no direct effect on levels of Foxp3 protein in allo-primed cells that were either tolerant, or aggressive, for donor antigen. However, we did find an effect of
axotrophin
on Foxp3: in the
axotrophin
null mouse, thymic Foxp3 transcripts were reduced compared to
axotrophin
wildtype littermates. To test whether these findings in the mouse were of potential significance in man we measured transcript levels of
axotrophin
and LIF in peripheral blood cell samples collected for a recently published clinical study concerning haematopoietic stem cell recipients. In controls, human peripheral blood CD4+CD25+cells contained significantly more FOXP3 and
axotrophin
than CD4+CD25-cells. In bone marrow autograft recipients, where peripheral blood cell samples directly represent both the grafted tissue and the immune response, both FOXP3 and
axotrophin
negatively correlated with graft versus host disease (GVHD). These data suggest that (i) thymic Foxp3+T cell development is influenced by
axotrophin
; and (ii) clinical auto-GVHD inversely correlates with
axotrophin
transcript expression as has been previously reported for FOXP3.
...
PMID:Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance. 1716 53